RAJESH SOLANKI

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (38)

• Clinico-demographic profile of pre-extensively drug-resistant pulmonary tuberculosis patients in India
  Indian Journal of Tuberculosis 2025 DOI: 10.1016/j.ijtb.2025.04.012
  +Save
• Treatment outcomes in people with diabetes and multidrug-resistant tuberculosis (MDR TB) enrolled in the STREAM clinical trial
  PLOS Global Public Health 2025 DOI: 10.1371/journal.pgph.0004259
  +Save
• A Study on Evaluation of Patient Satisfaction with National Tuberculosis Elimination Programme Services in Ahmedabad, India
  Indian Journal of Community Medicine 2025 DOI: 10.4103/ijcm.ijcm_416_23
  +Save
• Assessment of anxiety and depression among tuberculosis patients of Ahmedabad, India
  Indian Journal of Tuberculosis 2024 DOI: 10.1016/j.ijtb.2023.06.004
  +Save
• Effect of Bedaquiline and Delamanid Pharmacokinetics on Sputum Culture Conversion and Adverse Events in Drug-Resistant Tuberculosis
  Therapeutic Drug Monitoring 2024 DOI: 10.1097/FTD.0000000000001164
  +Save
• Long-term efficacy and safety of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): extended follow-up of an open-label, multicentre, randomised, non-inferiority trial
  The Lancet Respiratory Medicine 2024 DOI: 10.1016/S2213-2600(24)00186-3
  +Save
• QTc prolongation with bedaquiline treatment for drug-resistant pulmonary TB in a programmatic setting
  International Journal of Tuberculosis and Lung Disease 2023 DOI: 10.5588/ijtld.22.0406
  +Save
• Long-Term Intake of Linezolid Elevates Drug Exposure and Reduces Drug Clearance and Elimination in Adults with Drug-Resistant Pulmonary Tuberculosis
  Therapeutic Drug Monitoring 2023 DOI: 10.1097/FTD.0000000000001111
  +Save
• Linezolid Pharmacokinetics and Its Association with Adverse Drug Reactions in Patients with Drug-Resistant Pulmonary Tuberculosis
  Antibiotics 2023 DOI: 10.3390/antibiotics12040714
  +Save
• Economic evaluation of shortened, bedaquiline-containing treatment regimens for rifampicin-resistant tuberculosis (STREAM stage 2): a within-trial analysis of a randomised controlled trial
  The Lancet Global Health 2023 DOI: 10.1016/S2214-109X(22)00498-3
  +Save